NCT03127618

Brief Summary

Lorlatinib expanded access program

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 25, 2017

Completed
Last Updated

May 15, 2020

Status Verified

May 1, 2020

First QC Date

April 20, 2017

Last Update Submit

May 13, 2020

Interventions

LorlatinibDRUG

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult, Senior

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

lorlatinib

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2017

First Posted

April 25, 2017

Last Updated

May 15, 2020

Record last verified: 2020-05